Overall, their findings provided a novel understanding of the molecular function of HMGA2, and suggested a possible therapeutic application of DIC to prevent progression in colon cancer cells that over-express HMGA2 (121). The gene discussed is HMGA2; the disease is malignant colon neoplasm.